Webb26 okt. 2024 · Chair: Sharon Benzeno, Adaptive Biotechnologies Biomarkers to Guide Immunotherapy Chair: TBD Additional Emerging Therapeutics track themes focus on COVID Therapeutics on Day 1 The COVID Therapeutics Track (Day 1) SARS-CoV-2 vaccines: different vaccine strategies and robustness to viral evolution Webb27 mars 2024 · Dr. Sharon Benzeno is the Chief Business Development Officer and leads the Drug Discovery group of Adaptive Biotechnologies, a commercial-stage biotech …
Sharon Benzeno, PhD Life Science Washington
Webb9 mars 2024 · In this new role, Dr. Benzeno will continue to build out the necessary capabilities and partnerships to generate multiple opportunities stemming from … Webb3 feb. 2024 · Sharon Benzeno, PhD is the Chief Business Development Officer and leads the Drug Discovery group of Adaptive Biotechnologies. Prior to joining Adaptive in 2014, Sharon was Senior Director at Elsevier Inc., a healthcare informatics company. Prior to Elsevier, Sharon co-led the oncology business unit at Capgemini SE, a consulting and … dyson hot cool verbrauch
Sharon Benzeno - Chief Commercial Officer, Immune Medicine - Adaptive …
WebbFound 36 colleagues at Adaptive Biotechnologies. There is 1 other person named Sharon Benzeno on AllPeople. Find more info on AllPeople about Sharon Benzeno and Adaptive Biotechnologies, as well as people who work for similar businesses nearby, colleagues for other branches, and more people with a similar name. WebbSharon Benzeno is Chief Commercial Officer-Immune Medicine at Adaptive Biotechnologies Corp. In the past Dr. Benzeno was Senior Scientific Manager at AstraZeneca Plc and Senior Manager at Capgemini... Sharon Benzeno is Chief Commercial Officer-Immune Medicine at Adaptive Biotechnologies Corp. Webb6 okt. 2014 · Dr Sharon Benzeno, Senior Director, Business Development Bioinformatics at Reed Elsevier, considers where the industry goes from here Extracting actionable information from vast volumes of large ... dyson hot cool specifications